SEC
filing details

Document Details

Form
Filing Date
Jul 3, 2024
Document Date
Jul 2, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Ultragenyx Pharmaceutical Inc.
Issuer
Ultragenyx Pharmaceutical Inc.
Filer
Sanders Corazon (Corsee) D.
Sign up for Email Alerts
Email Alerts Sign-up